GlobeNewswire PharmaOriginal article
SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
Patent ExpiryapprovedCompositions and Methods for Potentiating Derivatives of 4-AminophenolsPositive
AI Analysis
Summary
NeuroThera Labs, a SciSparc subsidiary, received a Japanese patent for its proprietary 4-Aminophenol derivative combination for treating central nervous system disorders. This represents intellectual property protection in the Japanese market for the clinical-stage pharmaceutical company.
Outcome Details
Japanese Patent Office granted patent for proprietary therapeutic combination
Importance:3/10
Sentiment:
0.60
patent grantedJapanCNS disordersNeuroThera LabsSciSparc
Read the original article
Published by GlobeNewswire Pharma on August 12, 2026 12:25 PM